Literature DB >> 26350300

Aortic Fibrosis, Induced by High Salt Intake in the Absence of Hypertensive Response, is Reduced by a Monoclonal Antibody to Marinobufagenin.

Yulia N Grigorova1, Ondrej Juhasz2, Valentina Zernetkina2, Kenneth W Fishbein2, Edward G Lakatta2, Olga V Fedorova2, Alexei Y Bagrov3.   

Abstract

BACKGROUND: Marinobufagenin (MBG) is an endogenous Na/K-ATPase inhibitor, a natriuretic and a vasoconstrictor. MBG is implicated in salt-sensitive hypertension, cardiac hypertrophy, and initiate the pro-fibrotic signaling. Previously it was demonstrated that immunoneutralization of an endogenous MBG by 3E9 anti-MBG-antibody (mAb) in vivo lowered blood pressure (BP) and reversed cardiac fibrosis in salt-sensitive, and in partially nephrectomized rats. In the present study, we investigated whether mAb alleviates vascular remodeling induced in normotensive rats on high salt intake.
METHODS: Wistar rats (5 months old) received normal (CTRL; n = 8) or high salt intake (2% NaCl in drinking water) for 4 weeks ( n = 16). Rats from the group on a high salt intake were administered vehicle (SALT; n = 8) or mAb (50 µg/kg) (SALT-AB; n = 8) during the last week of high salt diet. BP, erythrocyte Na/K-ATPase activity, levels of MBG in plasma and 24-hour urine, and sensitivity of aortic explants to the vasorelaxant effect of sodium nitroprusside (SNP) were measured. Aortic collagen abundance was determined immunohistochemically.
RESULTS: In SALT vs. CTRL, heightened levels of MBG were associated with inhibition of erythrocyte Na/K-ATPase in the absence of BP changes. High salt intake was accompanied by a 2.5-fold increase in aortic collagen abundance and by a reduction of sensitivity of aortic explants to the vasorelaxant effect of SNP following endothelin-1-induced constriction. In the SALT-AB group, all NaCl-mediated effects were reversed by immunoneutralization of MBG.
CONCLUSIONS: High salt intake in young normotensive rats can induce vascular fibrosis via pressure-independent/MBG-dependent mechanisms, and this remodeling is reduced by immunoneutralization of MBG. © Published by Oxford University Press on behalf of American Journal of Hypertension Ltd 2015. This work is written by (a) US Government employees(s) and is in the public domain in the US.

Entities:  

Keywords:  Na/K-ATPase; blood pressure; high salt intake; hypertention; marinobu fagenin; monoclonal antibody; vascular fibrosis.

Mesh:

Substances:

Year:  2015        PMID: 26350300      PMCID: PMC5014083          DOI: 10.1093/ajh/hpv155

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  26 in total

1.  Reduction of Na/K-ATPase potentiates marinobufagenin-induced cardiac dysfunction and myocyte apoptosis.

Authors:  Changxuan Liu; Yan Bai; Yiliang Chen; Yu Wang; Yoann Sottejeau; Lijun Liu; Xiaomei Li; Jerry B Lingrel; Deepak Malhotra; Christopher J Cooper; Joseph I Shapiro; Zi-jian Xie; Jiang Tian
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

2.  Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure.

Authors:  Steven T Haller; David J Kennedy; Amjad Shidyak; George V Budny; Deepak Malhotra; Olga V Fedorova; Joseph I Shapiro; Alexei Y Bagrov
Journal:  Am J Hypertens       Date:  2012-03-01       Impact factor: 2.689

3.  High-salt intake induces cardiomyocyte hypertrophy in rats in response to local angiotensin II type 1 receptor activation.

Authors:  Isis A Katayama; Rafael C Pereira; Ellen P B Dopona; Maria H M Shimizu; Luzia N S Furukawa; Ivone B Oliveira; Joel C Heimann
Journal:  J Nutr       Date:  2014-08-13       Impact factor: 4.798

4.  Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats.

Authors:  Olga V Fedorova; Natalia I Agalakova; Mark I Talan; Edward G Lakatta; Alexei Y Bagrov
Journal:  J Hypertens       Date:  2005-08       Impact factor: 4.844

5.  Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists.

Authors:  Olga V Fedorova; Igor V Emelianov; Konstantin A Bagrov; Yulia N Grigorova; Wen Wei; Ondrej Juhasz; Elena V Frolova; Courtney A Marshall; Edward G Lakatta; Alexandra O Konradi; Alexei Y Bagrov
Journal:  J Hypertens       Date:  2015-08       Impact factor: 4.844

6.  Marinobufagenin is an upstream modulator of Gadd45a stress signaling in preeclampsia.

Authors:  Mohammad N Uddin; Darijana Horvat; Sharon Demorrow; Enoch Agunanne; Jules B Puschett
Journal:  Biochim Biophys Acta       Date:  2010-09-17

7.  Quantitative model of NMR chemical shifts of 23Na+ induced by TmDOTP: applications in studies of Na+ transport in human erythrocytes.

Authors:  M Puckeridge; B E Chapman; A D Conigrave; P W Kuchel
Journal:  J Inorg Biochem       Date:  2012-04-21       Impact factor: 4.155

Review 8.  Regulation of renal function and structure by the signaling Na/K-ATPase.

Authors:  Jeffrey X Xie; Xin Li; Zijian Xie
Journal:  IUBMB Life       Date:  2013-12-10       Impact factor: 3.885

9.  Coordinated shifts in Na/K-ATPase isoforms and their endogenous ligands during cardiac hypertrophy and failure in NaCl-sensitive hypertension.

Authors:  Olga V Fedorova; Mark I Talan; Natalia I Agalakova; Edward G Lakatta; Alexei Y Bagrov
Journal:  J Hypertens       Date:  2004-02       Impact factor: 4.844

10.  Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.

Authors:  Olga V Fedorova; Andrey S Simbirtsev; Nikolai I Kolodkin; Alexander Y Kotov; Natalia I Agalakova; Vladimir A Kashkin; Natalia I Tapilskaya; Anton Bzhelyansky; Vitaly A Reznik; Elena V Frolova; Elena R Nikitina; Georgy V Budny; Dan L Longo; Edward G Lakatta; Alexei Y Bagrov
Journal:  J Hypertens       Date:  2008-12       Impact factor: 4.844

View more
  10 in total

Review 1.  The Pressure of Aging.

Authors:  Majd AlGhatrif; Mingyi Wang; Olga V Fedorova; Alexei Y Bagrov; Edward G Lakatta
Journal:  Med Clin North Am       Date:  2017-01       Impact factor: 5.456

2.  Reducing Cardiac Fibrosis: Na/K-ATPase Signaling Complex as a Novel Target.

Authors:  X Fan; J Xie; J Tian
Journal:  Cardiovasc Pharm Open Access       Date:  2017-01-31

3.  Cardiotonic Steroids Induce Vascular Fibrosis Via Pressure-Independent Mechanism in NaCl-Loaded Diabetic Rats.

Authors:  Olga V Fedorova; Artem V Fadeev; Yulia N Grigorova; Courtney A Marshall; Valentina Zernetkina; Nikolai I Kolodkin; Natalia I Agalakova; Alexandra O Konradi; Edward G Lakatta; Alexei Y Bagrov
Journal:  J Cardiovasc Pharmacol       Date:  2019-11       Impact factor: 3.105

4.  Excessive Sodium Intake Leads to Cardiovascular Disease by Promoting Sex-Specific Dysfunction of Murine Heart.

Authors:  Xiuli Chen; Haiying Wu; Shenzhen Huang
Journal:  Front Nutr       Date:  2022-07-01

5.  Effect of Cardiotonic Steroid Marinobufagenin on Vascular Remodeling and Cognitive Impairment in Young Dahl-S Rats.

Authors:  Yulia N Grigorova; Ondrej Juhasz; Jeffrey M Long; Valentina I Zernetkina; Mikayla L Hall; Wen Wei; Christopher H Morrell; Natalia Petrashevskaya; Audrey Morrow; Katherine H LaNasa; Alexei Y Bagrov; Peter R Rapp; Edward G Lakatta; Olga V Fedorova
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

6.  Dietary Sodium Restriction Reduces Arterial Stiffness, Vascular TGF-β-Dependent Fibrosis and Marinobufagenin in Young Normotensive Rats.

Authors:  Yulia N Grigorova; Wen Wei; Natalia Petrashevskaya; Valentina Zernetkina; Ondrej Juhasz; Rachel Fenner; Christian Gilbert; Edward G Lakatta; Joseph I Shapiro; Alexei Y Bagrov; Olga V Fedorova
Journal:  Int J Mol Sci       Date:  2018-10-15       Impact factor: 5.923

7.  The endogenous cardiotonic steroid Marinobufagenin and decline in estimated glomerular filtration rate at follow-up in patients with arterial hypertension.

Authors:  Martin H Keppel; Grzegorz Piecha; Winfried März; Janne Cadamuro; Simon Auer; Thomas K Felder; Cornelia Mrazek; Hannes Oberkofler; Christian Trummer; Martin R Grübler; Verena Schwetz; Nicolas Verheyen; Marlene Pandis; Valentin Borzan; Elisabeth Haschke-Becher; Andreas Tomaschitz; Stefan Pilz
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

8.  Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt-Sensitive Hypertension.

Authors:  Yongqing Zhang; Wen Wei; Victoria Shilova; Natalia N Petrashevskaya; Valentina I Zernetkina; Yulia N Grigorova; Courtney A Marshall; Rachel C Fenner; Elin Lehrmann; William H Wood; Kevin G Becker; Edward G Lakatta; Alexei Y Bagrov; Olga V Fedorova
Journal:  J Am Heart Assoc       Date:  2019-10-02       Impact factor: 6.106

Review 9.  Cardiotonic Steroids and the Sodium Trade Balance: New Insights into Trade-Off Mechanisms Mediated by the Na⁺/K⁺-ATPase.

Authors:  Fatimah K Khalaf; Prabhatchandra Dube; Amal Mohamed; Jiang Tian; Deepak Malhotra; Steven T Haller; David J Kennedy
Journal:  Int J Mol Sci       Date:  2018-08-30       Impact factor: 5.923

Review 10.  Cardiotonic Steroids-A Possible Link Between High-Salt Diet and Organ Damage.

Authors:  Aneta Paczula; Andrzej Wiecek; Grzegorz Piecha
Journal:  Int J Mol Sci       Date:  2019-01-30       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.